Trial Profile
A Double-blind, Randomized, Placebo-controlled, Parallel Design Study, in Patients With Type 2 Diabetes Mellitus, to Investigate the Safety, Pharmacokinetics and Pharmacodynamics Interactions of Multiple Oral Doses of ASP1941 and Metformin
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 31 Jul 2017
Price :
$35
*
At a glance
- Drugs Ipragliflozin (Primary) ; Metformin
- Indications Type 2 diabetes mellitus
- Focus Adverse reactions
- Sponsors Astellas Pharma
- 13 Jul 2012 Results published in Clinical Therapeutics.
- 16 Sep 2011 Results presented at the 47th Annual Meeting of the European Association for the Study of Diabetes.
- 02 Mar 2011 New trial record